Nanogen Pharmaceutical Biotechnology JSC has been asked to provide more data for consideration before a registration certificate of conditional circulation for its Nano Covax can be granted.
The National Committee for Ethics in Biomedical Research under the Ministry of Health (MoH) has agreed that the mid-term results from Nano Covax's phase 3 clinical trials will be submitted to the Advisory Council for the Registration of Circulation of Drugs and Medicinal Ingredients for considering the issuance of a registration certificate for the conditional circulation of the vaccine.
US companies are seeing Vietnam as a "land of hope" following US Vice President Kamala Harris's visit to the Southeast Asian nation from August 24-26, reported the Vietnam Investment Review.
The Hanoi Medical University on August 15 began the first phase of clinical trials of the ARCT-154 COVID-19 vaccine. It is also the first vaccine produced on the basis of mRNA technology in Vietnam.
The Hanoi Medical University will start on August 15 Phase 1 of clinical trial of the mRNA COVID-19 vaccine named ARCT-154 vaccine with 100 volunteers from Hanoi.
The Hanoi Medical University will on August 15 start the first phase of clinical trials of COVID-19 vaccine ARCT-154, a mRNA vaccine developed by US company Arcturus Therapeutics, Inc, which transferred the technology to a company in Vietnam.
Conglomerate Vingroup has signed an agreement with Arcturus Therapeutics medicines biotechnology company of the US on the transfer of COVID-19 vaccine production technology.
Health
